CRT Pioneer Fund, Cancer Research UK, NCI Collaborate to Boost Research Against 'Undruggable' RAS
April 21, 2017
April 21, 2017
LONDON, April 21 -- Cancer Research UK issued the following news release:
Cancer Research UK and the Cancer Research Technology Pioneer Fund (CPF)* have committed Pounds2.5 million in collaboration with the National Cancer Institute (NCI) in the US to tackle one of the toughest challenges in cancer that has thwarted researchers for more than 30 years.
Scientists will develop and test promising new molecules for targeting RAS, one of the most common driving mutations . . .
Cancer Research UK and the Cancer Research Technology Pioneer Fund (CPF)* have committed Pounds2.5 million in collaboration with the National Cancer Institute (NCI) in the US to tackle one of the toughest challenges in cancer that has thwarted researchers for more than 30 years.
Scientists will develop and test promising new molecules for targeting RAS, one of the most common driving mutations . . .